Clinical Trial Update: Neuroprotection Impact of Cyclosporin A in Cerebral Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the neuroprotective impact of Cyclosporin A in cerebral infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Cyclosporin A (cyclosporine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Stroke | Phase 2 | Status: COMPLETED